FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Fund ProfileTema Oncology ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
CANC
Tema Oncology ETF ETF AnalysisComprehensive ETF analysis for Tema Oncology ETF (CANC) including NAV, expense ratio, dividend yield, sector breakdown, and holdings data.ETF AnalysisCANC
CANC
Tema Oncology ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
CANC
  1. Home
  2. Screener
  3. Tema Oncology ETFCANCETF
Tema Oncology ETF Logo

Tema Oncology ETF

ETF
🇺🇸CANC•NASDAQ•Equity

Your view on CANC

Tema Oncology ETF Logo

Tema Oncology ETF

ETFTema
🇺🇸CANC•NASDAQ•Equity
AUM (USD)$215.24M
Expense Ratio0.99%
Yield (TTM)0.05%
Holdings56

Sentiment

—

AUM (USD)

$215.24M

Expense Ratio

0.99%

Yield (TTM)

0.05%

Holdings

56

Sentiment

—
Fund Overview

Overview

What the fund invests in, who runs it, and what it costs.

Tema Oncology ETF (CANC) is an Equity fund from Tema, listed since 2023, with $215.2M in assets under management, a 0.99% expense ratio and a NAV of $42.12 USD.

Overview for Tema Oncology ETF

Fund Type
ETF
Fund Issuer
Tema
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
August 14, 2023
Domicile
US
Website
temaetfs.com/canc
Fund Type
ETF
Fund Issuer
Tema
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
August 14, 2023
Domicile
US
Website
temaetfs.com/canc
Fund Type
ETF
Fund Issuer
Tema
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
August 14, 2023
Domicile
US
Website
temaetfs.com/canc

About this fund

The Tema Oncology ETF (CANC) seeks to invest in companies that potentially stand to benefit from further advances in oncology related biotechnology and healthcare.

Fund Data

Price Chart

Market price history and trading volume.

Key Facts

Cost, yield, size, and the fund's reference data.

Equity

Expense Ratio

0.99%

Yield (TTM)

0.05%

AUM

$215.24M

Fund Details

NAV$42.12 USD
Holdings56
Average Volume25.1K
Inception DateAugust 14, 2023
Asset ClassEquity
Fund IssuerTema
DomicileUS
ISINUS87975E7013
CUSIP87975E701
NAV CurrencyUSD

Expense Ratio

0.99%

Dividend Yield (TTM)

0.05%

Assets Under Management

$215.24M

NAV

$42.12 USD

Holdings

56

Average Volume

25.1K

Inception Date

August 14, 2023

Asset Class

Equity

Fund Issuer

Tema

Domicile

US

ISIN

US87975E7013

CUSIP

87975E701

NAV Currency

USD

Expense Ratio

0.99%

Dividend Yield (TTM)

0.05%

Assets Under Management

$215.24M

NAV

$42.12 USD

Holdings

56

Average Volume

25.1K

Inception Date

August 14, 2023

Asset Class

Equity

Fund Issuer

Tema

Domicile

US

ISIN

US87975E7013

CUSIP

87975E701

NAV Currency

USD

Distributions · last 12 months

Annual · 1 payment

Ex-datePaidAmount
Dec 10, 2025Dec 11, 2025$0.0196
Total, 12 months$0.02 a share

Dividend yield (TTM) 0.05% = $0.02 paid per share in the 12 months to Nov 20, 2026 ÷ the $38.86 price. Past distributions; future payments can differ.

Data last updated: Nov 13, 2026, 08:11 AM

Sectors

How the fund's assets are split across sectors.

1 sectors
  • 1Healthcare
    100.0%

Top sector

Healthcare

Top weight

100.0%

Top 3 weight

100.0%

Holdings

The securities the fund owns, by weight.

55 positions
1GMABGENMAB A/S
6.47%
2RVMDREVOLUTION MEDICINES INC
5.54%
3LLYELI LILLY & CO
5.13%
4COGTCOGENT BIOSCIENCES INC
4.47%
5ONCBEONE MEDICINES LTD
4.45%
6MRKMERCK & CO INC
4.36%
7EXELEXELIXIS INC
3.82%
8CGONCG ONCOLOGY INC
3.76%
9NOVN.SWNOVARTIS AG
3.74%
10ABBVABBVIE INC
3.48%
11BBIOBRIDGEBIO PHARMA INC
3.42%
12RHHBYROCHE HOLDING AG
3.36%
13ELVNENLIVEN THERAPEUTICS INC
3.06%
14HALOHALOZYME THERAPEUTICS INC
2.99%
15BMYBRISTOL-MYERS SQUIBB CO
2.49%

Concentration

Total Holdings55
Top 10 Weight45.20%
Top HoldingGMAB
Top Weight6.47%
1GMABGENMAB A/S
6.47%
2RVMDREVOLUTION MEDICINES INC
5.54%
3LLYELI LILLY & CO
5.13%
4COGTCOGENT BIOSCIENCES INC
4.47%
5ONCBEONE MEDICINES LTD
4.45%
6MRKMERCK & CO INC
4.36%
7EXELEXELIXIS INC
3.82%
8CGONCG ONCOLOGY INC
3.76%
9NOVN.SWNOVARTIS AG
3.74%
10ABBVABBVIE INC
3.48%
11BBIOBRIDGEBIO PHARMA INC
3.42%
12RHHBYROCHE HOLDING AG
3.36%
13ELVNENLIVEN THERAPEUTICS INC
3.06%
14HALOHALOZYME THERAPEUTICS INC
2.99%
15BMYBRISTOL-MYERS SQUIBB CO
2.49%

Total Holdings

55

Top 10 Weight

45.20%

Top Holding

GMAB

Top Weight

6.47%

1GMABGENMAB A/S
6.47%$12.79M
2RVMDREVOLUTION MEDICINES INC
5.54%$10.95M
3LLYELI LILLY & CO
5.13%$10.14M
4COGTCOGENT BIOSCIENCES INC
4.47%$8.84M
5ONCBEONE MEDICINES LTD
4.45%$8.80M
6MRKMERCK & CO INC
4.36%$8.61M
7EXELEXELIXIS INC
3.82%$7.54M
8CGONCG ONCOLOGY INC
3.76%$7.43M
9NOVN.SWNOVARTIS AG
3.74%$7.39M
10ABBVABBVIE INC
3.48%$6.88M
11BBIOBRIDGEBIO PHARMA INC
3.42%$6.76M
12RHHBYROCHE HOLDING AG
3.36%$6.65M
13ELVNENLIVEN THERAPEUTICS INC
3.06%$6.06M
14HALOHALOZYME THERAPEUTICS INC
2.99%$5.92M
15BMYBRISTOL-MYERS SQUIBB CO
2.49%$4.92M

Total Holdings

55

Top 10 Weight

45.20%

Top Holding

GMAB

Top Weight

6.47%

Peer Comparison

Comparables

Funds similar to this one.

Side by side on what an ETF is compared on16 funds
FundAsset classExpense ratioAssetsHoldings
CANCTema Oncology ETFThis fundEquity0.99%$215M56

Comparable funds

  • BATTAmplify Lithium & Battery Technology ETFEquity0.59%$90M52
  • CSDInvesco S&P Spin-Off ETFEquity0.66%$214M31
  • CVMCCalvert US Mid-Cap Core Responsible Index ETFUS Equity0.15%$118M0
  • KARSKraneShares Electric Vehicles & Future Mobility Index ETFEquity0.69%$63M58
  • MAVFMatrix Advisors Value ETFEquity0.75%$94M0
  • MINVMatthews Asia Innovators Active ETF MINVEquity0.79%$150M41
  • ONLNProShares - Online Retail ETFEquity0.58%$62M24
  • OVLHOverlay Shares Hedged Large Cap Equity ETFEquity0.80%$101M9

More Tema ETFs

  • PRVTTema Listed Private Managers ETFEquity0.99%$234,6561
  • TOLLTema Durable Quality ETFEquity0.55%$46M39
  • WELDTema U.S. Manufacturing & Reshoring ETFEquity0.75%$194M22
  • ARMYTema International Defense Innovation ETFEquity0.75%$12M37
  • DISKTEMA MEMORY ETFEquity0.75%$43M18
  • DSPYTema S&P 500 Historical Weight ETF StrategyEquity0.18%$987M505
  • HRTSTema Cardiovascular and Metabolic ETFEquity0.99%$58M46
  • NASATema Space Innovators ETFEquity0.75%$873M37
Ownership & News

Fund Holders

Institutions that own shares of this fund.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for this company. Press releases and market coverage, newest first.

News

Latest Market News

News

Latest Market News